195 related articles for article (PubMed ID: 29899876)
1. Hypoxia-targeted gold nanorods for cancer photothermal therapy.
Chen Y; Bian X; Aliru M; Deorukhkar AA; Ekpenyong O; Liang S; John J; Ma J; Gao X; Schwartz J; Singh P; Ye Y; Krishnan S; Xie H
Oncotarget; 2018 May; 9(41):26556-26571. PubMed ID: 29899876
[TBL] [Abstract][Full Text] [Related]
2. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
[TBL] [Abstract][Full Text] [Related]
3. Gold nanorods assisted photothermal therapy of bladder cancer in mice: A computational study on the effects of gold nanorods distribution at the centre, periphery, and surface of bladder cancer.
Cheong JK; Ooi EH; Chiew YS; Menichetti L; Armanetti P; Franchini MC; Alchera E; Locatelli I; Canu T; Maturi M; Popov V; Alfano M
Comput Methods Programs Biomed; 2023 Mar; 230():107363. PubMed ID: 36720181
[TBL] [Abstract][Full Text] [Related]
4. Electrostatically self-assembled gold nanorods with chondroitin sulfate for targeted photothermal therapy for melanoma.
Sano K; Miki M; Tanaka T; Munemura M; Munekane M; Yamasaki T; Mukai T
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102402. PubMed ID: 34144259
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
[TBL] [Abstract][Full Text] [Related]
6. Implantable Photothermal Agents based on Gold Nanorods-Encapsulated Microcube.
Moon HJ; Ku M; Lee H; Yoon N; Yang J; Bong KW
Sci Rep; 2018 Sep; 8(1):13683. PubMed ID: 30209277
[TBL] [Abstract][Full Text] [Related]
7. Photothermal conversion efficiency and cytotoxic effect of gold nanorods stabilized with chitosan, alginate and poly(vinyl alcohol).
Almada M; Leal-Martínez BH; Hassan N; Kogan MJ; Burboa MG; Topete A; Valdez MA; Juárez J
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():583-593. PubMed ID: 28532069
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
9. Homing peptide-conjugated gold nanorods: the effect of amino acid sequence display on nanorod uptake and cellular proliferation.
Alkilany AM; Boulos SP; Lohse SE; Thompson LB; Murphy CJ
Bioconjug Chem; 2014 Jun; 25(6):1162-71. PubMed ID: 24892190
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer photothermal therapy based on gold nanorods targeted by covalently-coupled bombesin peptide.
Heidari Z; Salouti M; Sariri R
Nanotechnology; 2015 May; 26(19):195101. PubMed ID: 25900323
[TBL] [Abstract][Full Text] [Related]
11. PAA-derived gold nanorods for cellular targeting and photothermal therapy.
Kirui DK; Krishnan S; Strickland AD; Batt CA
Macromol Biosci; 2011 Jun; 11(6):779-88. PubMed ID: 21438153
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
[TBL] [Abstract][Full Text] [Related]
13. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.
Heidari Z; Sariri R; Salouti M
J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991
[TBL] [Abstract][Full Text] [Related]
14. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
[TBL] [Abstract][Full Text] [Related]
15. Gold nanorods/mesoporous silica-based nanocomposite as theranostic agents for targeting near-infrared imaging and photothermal therapy induced with laser.
Liu Y; Xu M; Chen Q; Guan G; Hu W; Zhao X; Qiao M; Hu H; Liang Y; Zhu H; Chen D
Int J Nanomedicine; 2015; 10():4747-61. PubMed ID: 26251596
[TBL] [Abstract][Full Text] [Related]
16. Nuclear-Targeting Gold Nanorods for Extremely Low NIR Activated Photothermal Therapy.
Pan L; Liu J; Shi J
ACS Appl Mater Interfaces; 2017 May; 9(19):15952-15961. PubMed ID: 28447447
[TBL] [Abstract][Full Text] [Related]
17. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic Acid-Functionalized Gold Nanorods with pH/NIR Dual-Responsive Drug Release for Synergetic Targeted Photothermal Chemotherapy of Breast Cancer.
Xu W; Qian J; Hou G; Suo A; Wang Y; Wang J; Sun T; Yang M; Wan X; Yao Y
ACS Appl Mater Interfaces; 2017 Oct; 9(42):36533-36547. PubMed ID: 28975790
[TBL] [Abstract][Full Text] [Related]
19. Effects of gold nanorod concentration on the depth-related temperature increase during hyperthermic ablation.
Jang B; Kim YS; Choi Y
Small; 2011 Jan; 7(2):265-70. PubMed ID: 21213392
[TBL] [Abstract][Full Text] [Related]
20. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
